Literature DB >> 9530559

Three-dimensional structure of a human Fab with high affinity for tetanus toxoid.

C Faber1, L Shan, Z Fan, L W Guddat, C Furebring, M Ohlin, C A Borrebaeck, A B Edmundson.   

Abstract

BACKGROUND: The wide range of antibody specificity and affinity results from the differing shapes and chemical compositions of their binding sites. These shapes range from discrete grooves in antibodies elicited by linear oligomers of nucleotides and carbohydrates to shallow depressions or flat surfaces for accommodation of proteins, peptides and large organic compounds.
OBJECTIVES: To determine the Fab structure of a high-affinity human antitoxin antibody. To explore structural features which enable the antibody to bind to intact tetanus toxoid, peptides derived from the sequence of the natural immunogen and antigenic mimics identified by combinatorial chemistry. To explain why this Fab shows a remarkable tendency to produce crystals consistently diffracting to d spacings of 1.7-1.8 A. To use this information to engineer a strong tendency to crystallize into the design of other Fabs. STUDY
DESIGN: The protein was crystallized in hanging or sitting drops by a microseeding technique in polyethylene glycol (PEG) 8000. Crystals were subjected to X-ray analysis and the three-dimensional structure of the Fab was determined by the molecular replacement method. Interactive computer graphics were employed to fit models to electron density maps, survey the structure in multiple views and discover the crystal packing motif of the protein.
RESULTS: Exceptionally large single crystals of this protein have been obtained, one measuring 5 x 3 x 2 mm (l x w x d). The latter was cut into six irregular pieces, each retaining the features of the original in diffracting to high resolution (1.8 A) with little decay in the X-ray beam. In an individual Fab, the active site is relatively flat and it seems likely that the protein antigen and derivative peptides are tightly held on the outer surface without significant penetration into the interior. There is no free space to accommodate even a dipeptide between VH and VL. One of the unique features of the B7-15A2 Fab is a large aliphatic ridge dominating the center of the active site. The CDR3 of the H chain contributes significantly to this ridge, as well as to adjoining regions projected to be important for the docking of the antigen. Both the ease of crystallization and the favorable diffraction properties are mainly attributable to the tight packing of the protein molecules in the crystal lattice. DISCUSSION: The B7-15A2 active site provides a stable and well defined platform for high affinity docking of proteins, peptides and their mimotopes. The advantages for future developments are suggested by the analysis of the crystal properties. It should be possible to incorporate the features promoting crystallization, close packing and resistance to radiation damage into engineered human antibodies without altering the desired specificities and affinities of their active sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530559     DOI: 10.1016/s1380-2933(97)10003-3

Source DB:  PubMed          Journal:  Immunotechnology        ISSN: 1380-2933


  15 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556.

Authors:  Stefan Harth; Alexander Kotzsch; Walter Sebald; Thomas Dieter Mueller
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-29

3.  A residue-specific shift in stability and amyloidogenicity of antibody variable domains.

Authors:  Cardine N Nokwe; Martin Zacharias; Hisashi Yagi; Manuel Hora; Bernd Reif; Yuji Goto; Johannes Buchner
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

4.  Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody.

Authors:  Roy Eylenstein; Daniel Weinfurtner; Stefan Härtle; Ralf Strohner; Jark Böttcher; Martin Augustin; Ralf Ostendorp; Stefan Steidl
Journal:  MAbs       Date:  2015-09-25       Impact factor: 5.857

5.  Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.

Authors:  Paul A Ramsland; Simon S Terzyan; Gwendolyn Cloud; Christina R Bourne; William Farrugia; Gordon Tribbick; H Mario Geysen; Carolyn R Moomaw; Clive A Slaughter; Allen B Edmundson
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

6.  A selection fit mechanism in BMP receptor IA as a possible source for BMP ligand-receptor promiscuity.

Authors:  Stefan Harth; Alexander Kotzsch; Junli Hu; Walter Sebald; Thomas D Mueller
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

7.  Covalent antibody display--an in vitro antibody-DNA library selection system.

Authors:  Herald Reiersen; Inger Løbersli; Geir Å Løset; Else Hvattum; Bjørg Simonsen; John E Stacy; Duncan McGregor; Kevin Fitzgerald; Martin Welschof; Ole H Brekke; Ole J Marvik
Journal:  Nucleic Acids Res       Date:  2005-01-14       Impact factor: 16.971

8.  Combination of specific single chain antibody variable fragment and siRNA has a synergistic inhibitory effect on the propagation of avian influenza virus H5N1 in chicken cells.

Authors:  Shuang Wang; Peng Zhang; Fei He; Ji-Gui Wang; Jia-Zeng Sun; Zhi-Li Li; Bao Yi; Ji Xi; Ya-Ping Mao; Qiang Hou; Dao-Li Yuan; Zi-Ding Zhang; Wei-Quan Liu
Journal:  Virol J       Date:  2014-11-29       Impact factor: 4.099

9.  Identification of antigen-specific B cell receptor sequences using public repertoire analysis.

Authors:  Johannes Trück; Maheshi N Ramasamy; Jacob D Galson; Richard Rance; Julian Parkhill; Gerton Lunter; Andrew J Pollard; Dominic F Kelly
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

10.  Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.

Authors:  Yang Shen; Lin Zeng; Aiping Zhu; Tim Blanc; Dipa Patel; Anthony Pennello; Amtul Bari; Stanley Ng; Kris Persaud; Yun Kenneth Kang; Paul Balderes; David Surguladze; Sagit Hindi; Qinwei Zhou; Dale L Ludwig; Marshall Snavely
Journal:  MAbs       Date:  2013-04-08       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.